S-Myc Inhibitors

Chemical inhibitors of S-Myc target various aspects of this protein's function, which is critical for its role in gene expression regulation. The small molecule 10058-F4 operates by inhibiting S-Myc-Max dimerization, a crucial step for S-Myc's DNA-binding capacity, thus leading to functional inhibition. Similarly, 10074-G5 induces a conformational change in the S-Myc-Max complex, impairing S-Myc's ability to bind to DNA and therefore its transcriptional control.

JQ1 is another compound that indirectly inhibits S-Myc by displacing bromodomain-containing protein 4 (BRD4) from chromatin, which is essential for BRD4's recruitment of the positive transcription elongation factor b (P-TEFb) to the S-Myc protein, thus reducing S-Myc activity. MYCi975 and MYCi361 both destabilize S-Myc by disrupting its interaction with the SP1 transcription factor, leading to a decrease in S-Myc stability and function. CBL0137 interacts with the FACT complex, thereby impairing S-Myc's chromatin-associated activities, an essential aspect of its function. DB1976 directly blocks S-Myc/Max dimerization, leading to inhibited DNA binding and transcriptional regulation by S-Myc. SGC-CBP30 targets the bromodomain of the CREB-binding protein (CBP), inhibiting CBP-mediated transcription of S-Myc. Lastly, Bromosporine serves as a non-selective bromodomain inhibitor, disrupting various bromodomain-containing proteins and thus affecting S-Myc regulated transcriptional networks. All these chemicals exert their inhibitory effects by directly or indirectly impairing the ability of S-Myc to regulate gene transcription, either by destabilizing the protein itself, blocking its interactions with essential cofactors, or interfering with the protein complexes that facilitate its transcriptional activity.